Article info

Download PDFPDF

Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al
Free

Authors

  • Martin Aringer Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Karen Costenbader Division of Rheumatology and Immunology, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Thomas Dörner Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Sindhu R Johnson Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University Health Network, Mount Sinai Hospital, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Martin Aringer, Internal Medicine III, Medical Faculty, Technical University of Dresden, Dresden D-01307, Germany; martin.aringer{at}uniklinikum-dresden.de
View Full Text

Citation

Aringer M, Costenbader K, Dörner T, et al
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al

Publication history

  • Received September 10, 2019
  • Accepted September 10, 2019
  • First published September 18, 2019.
Online issue publication 
July 13, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.